Technical Analysis for ZNTL - Zentalis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 41.3 -1.01% -0.42
ZNTL closed down 1.01 percent on Thursday, May 28, 2020, on 88 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A N/A Up
Historical ZNTL trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -1.01%
Multiple of Ten Bullish Other -1.01%
Outside Day Range Expansion -1.01%
Wide Bands Range Expansion -1.01%
1,2,3 Pullback Bullish Bullish Swing Setup 4.19%
Narrow Range Bar Range Contraction 4.19%
NR7 Range Contraction 4.19%
Multiple of Ten Bearish Other 4.19%
Inside Day Range Contraction 4.19%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Zentalis Pharmaceuticals LLC is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin Bunker on December 23, 2014 and is headquartered in New York, NY.
Biopharmaceutical Cancer Drugs Hormones Tyrosine Kinase Receptors Epidermal Growth Factor Receptor Her2/Neu Metastatic Breast Cancer Antiestrogens Selective Estrogen Receptor Degraders

Is ZNTL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.6099
52 Week Low 23.25
Average Volume 187,069
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 36.87
10-Day Moving Average 40.10
Average True Range 3.76
ADX 52.26
+DI 30.55
-DI 6.65
Chandelier Exit (Long, 3 ATRs ) 37.33
Chandelier Exit (Short, 3 ATRs ) 39.29
Upper Bollinger Band 44.42
Lower Bollinger Band 29.31
Percent B (%b) 0.79
BandWidth 40.99
MACD Line 3.65
MACD Signal Line 3.66
MACD Histogram -0.0065
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.86
Resistance 3 (R3) 45.06 44.08 44.27
Resistance 2 (R2) 44.08 43.17 43.98 44.07
Resistance 1 (R1) 42.69 42.61 42.20 42.49 43.87
Pivot Point 41.70 41.70 41.46 41.60 41.70
Support 1 (S1) 40.31 40.79 39.82 40.11 38.73
Support 2 (S2) 39.33 40.23 39.23 38.53
Support 3 (S3) 37.94 39.33 38.33
Support 4 (S4) 37.74